Second Genome: Second Genome Virtual KOL Event Highlighted Critical Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease (IBD)

SG-5-00455, the Company's development candidate for the treatment of IBD, aims to restore mucosal healing by targeting PAI-1/2 BRISBANE, Calif., Feb. 24, 2022 /PRNewswire/ --...